iridium has been researched along with naphthoquinones in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cieslak, M; Donevski, S; Kazmierczak-Baranska, J; Lorenz, IP; Nawrot, B; Rohbogner, CJ; Wirth, S | 1 |
| Lin, H; Xiao, LJ; Xie, JH; Yu, HM; Zhou, MJ; Zhou, QL | 1 |
| Chiniforoshan, H; Tabrizi, L | 1 |
3 other study(ies) available for iridium and naphthoquinones
| Article | Year |
|---|---|
Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.
Topics: Antineoplastic Agents; Caspase 3; Caspase 7; Cell Death; Cell Line, Tumor; Cells, Cultured; Circular Dichroism; Coordination Complexes; Crystallography, X-Ray; DNA; HeLa Cells; Humans; Iridium; Models, Molecular; Naphthoquinones; Neoplasms; Rhodium | 2010 |
Enantioselective Approach to (-)-Hamigeran B and (-)-4-Bromohamigeran B via Catalytic Asymmetric Hydrogenation of Racemic Ketone To Assemble the Chiral Core Framework.
Topics: Biological Products; Catalysis; Cyclopentanes; Hydrogenation; Iridium; Ketones; Kinetics; Molecular Structure; Naphthoquinones; Stereoisomerism | 2016 |
Designing new iridium(iii) arene complexes of naphthoquinone derivatives as anticancer agents: a structure-activity relationship study.
Topics: Antineoplastic Agents; Apoptosis; Benzene; Cell Line, Tumor; DNA; Drug Design; Drug Stability; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Space; Iridium; Naphthoquinones; Reactive Oxygen Species; Structure-Activity Relationship | 2017 |